The TGF-β is observed to be upregulated in pancreatic cancer, and this upregulation is implicated with venous invasion, disease progression, advanced tumor stages, liver metastasis, and eventually poor survival rate (66–70). This evidence concerns the gene TGFB1 and neoplasm.